# Phase 2.12 — Discovery & Scope Audit Report

**Status:** BLOCKED / AWAITING AUTHORITATIVE ROADMAP SPECIFICATION  
**Date:** 2026-08-29  
**Auditor:** Principal Software Architect & Lead Healthcare Engineer  

---

## 1. Baseline & Repository Inspection Summary

An exhaustive repository inspection was performed across all workspace packages and applications:

1. **Current Application Shell (`apps/partner-platform/src/components/PartnerPlatformShell.tsx`)**:
   - Registered and active modules (Phases 2.1 to 2.11):
     - `organization-foundation` (Phase 2.1 — Partner Foundation)
     - `staff-administration` (Phase 2.2 — Staff Administration)
     - `doctor-management` (Phase 2.3 — Doctor & OPD Roster)
     - `patient-registration` (Phase 2.4 — Patient Registration / MPI)
     - `encounters-visits` (Phase 2.5 — Encounter & Visit Management)
     - `clinical-consultation` (Phase 2.6 — Clinical Consultation & EMR)
     - `clinical-investigation` (Phase 2.7 — Laboratory & Diagnostic Investigation)
     - `pharmacy-medication` (Phase 2.8 — Pharmacy & Medication Dispensing)
     - `billing-revenue-cycle` (Phase 2.9 — Billing & Revenue Cycle Management)
     - `insurance-claims` (Phase 2.10 — Insurance, TPA & Third-Party Payer Management)
     - `procurement-supply-chain` (Phase 2.11 — Procurement, Supply Chain & Vendor Management)

2. **Database Schemas & Migrations (`packages/database`)**:
   - `packages/database/src/schema/clinical/index.ts` contains schemas for Phases 2.1 through 2.11 (5539 lines, 0025 migrations).
   - No Phase 2.12 tables or entities currently exist in the database.

3. **API Contracts (`packages/api-contracts`)**:
   - Contracts exist for Phases 2.1 through 2.11 under `packages/api-contracts/src/partner-platform/`.
   - No Phase 2.12 contract definitions or DTO schemas exist.

4. **Roadmap & Architecture Documentation (`docs/`)**:
   - `docs/ARCHITECTURE.md`, `docs/BOUNDARIES.md`, `docs/DESIGN_SYSTEM.md`, `docs/SECURITY.md` define general architecture, tenant compound isolation (`tenantId`, `partnerId`, `organizationId`, `branchId`), and boundaries.
   - `apps/partner-platform/src/index.ts` lists a historical constant `PHASE_2_CLINICAL_DOMAINS` containing standard clinical domains, but lacks an authoritative numbered Master Prompt / roadmap specification for Phase 2.12.

---

## 2. Discovery Evaluation

Per the **Phase 2.12 Discovery Gate** and **Primary Rule**:
- **Rule 13:** *Identify the EXACT Phase 2.12 scope from the authoritative DOC SEARCH roadmap/source available in the project.*
- **Rule 14:** *DO NOT invent a Phase 2.12 domain if the authoritative roadmap cannot be found.*
- **Directive:** *IF THE AUTHORITATIVE ROADMAP ENTRY IS NOT FOUND: STOP. Do NOT select a random domain. Do NOT create speculative database tables. Do NOT create speculative UI. Do NOT mark Phase 2.12 complete. Report: PHASE 2.12 = BLOCKED, Reason = Authoritative Phase 2.12 scope not found.*

---

## 3. Required Missing Source / Input

To proceed with Phase 2.12 implementation without speculative drift, the authoritative **Phase 2.12 Master Development Prompt / Specification** is required (similar to Phase 2.10 Insurance/Claims and Phase 2.11 Procurement/Supply Chain), specifying:
- Exact Domain Name and primary shell identifier
- Complete Database Table Schemas & Foreign Keys
- API Contracts, DTOs & Validation Rules
- Service Methods & State Machine Workflows
- Required UI Dialogs (with specific validation and action handlers)
- Required Operational Views & Analytics
- Multi-tier RBAC permissions and ScopeGuard rules
